Jul 2026· Current Applied Science and Technology· 0 citations
Abstract
The family Orchidaceae is one of the most taxonomically diverse groups of angiosperms, recognized for their ornamental significance and their content of pharmacologically relevant secondary metabolites. This review critically evaluates the phytochemical diversity, bioactivities, and potential of Orchidaceae species as natural sources for the development of functional food products. This review is based on a comprehensive literature survey of 32 peer-reviewed articles indexed in Scopus and PubMed through April 2025, which reports the presence of diverse bioactive compounds-mainly phenolics, flavonoids, alkaloids, tannins, and anthocyanins in various orchid species and plant tissues. These compounds exhibit a broad spectrum of biological activities, including antioxidants, antimicrobial, anticancer, anti-inflammatory, antidiabetic, anti-aging, photoprotective, and neuropharmacological effects. The concentration and composition of these metabolites depend on species differences, plant organ specificity, and extraction methods. Cumulative evidence underscores the underutilized potential of orchids as phytochemical reservoirs for nutraceutical applications. However, further translational research on bioavailability, safety, and functional stability in complex food systems is essential to enable their practical application in consumer health products. This review advocates intensive multidisciplinary research on Orchidaceae to open up new opportunities in the functional food and health-promoting bioactive industries.
This review provides a comprehensive overview of the phytochemical composition, biological activities, and bioeconomic potential of five selected woody species occurring in the Karditsa region and identifies future research directions for the sustainable exploitation of selected woody flora from the Karditsa region.
Christos Chiolos, V. Athanasiadis, Ekaterini Koura et al.· Applied Sciences· 0 citations
Callistemon citrinus (Myrtaceae), a traditional medicinal herb, has been
used to treat various disorders associated with metabolism, digestion, inflammation, and respiration.
Recent discoveries in pharmacology, together with the herb's diverse phytochemistry, have raised
the possibility of multiple targets for medicinal interventions. This review attempts to critically analyse
the phytochemical profile and pharmacology of C. citrinus.
PubMed, Scopus, Web of Science, and ScienceDirect databases were used to do a systematic
literature search until 2025. PRISMA-based guidelines were used to screen and analyze
peer-reviewed research, including in vitro, in vivo, and in silico studies. Information on biological
activity, mechanisms, safety profiles, and phytochemistry was retrieved.
Flavonoids, terpenoids, phenolic acids, tannins, and sterols are just a few of the many bioactive
components found in C. citrinus. Pharmacological research demonstrates the antioxidant, antibacterial,
anti-inflammatory, antidiabetic, gastroprotective, neuroprotective, and anticancer properties.
While other activities remain restricted to experimental models with inconsistent methodological
quality, antioxidant and antibacterial benefits are supported by rather consistent preclinical data.
Mechanistically, oxidative stress, inflammatory mediators, and metabolic pathways are all modulated.
However, there is little experimental confirmation; new in silico research points to multi-target
interactions. In acute and subacute models, toxicological research shows a favourable safety profile.
C. citrinus has various pharmacological properties due to its unique phytochemistry.
Although there is substantial research on its antioxidant and anti-microbial properties, all the information
is based on experimental data. There is a need for clinical trials to prove its potential therapeutic
benefits.
Although C. citrinus has remarkable therapeutic promise, the paucity of clinical studies
and pharmacokinetic data, and the lack of standardization hinder its clinical translation. Welldesigned
clinical trials, bioavailability improvement, and mechanistic validation should be the top
priorities for future research.
Shankul Kumar, Vedant Kumar Prajapati, A. Patel et al.· Current Chemical Biology· 0 citations
Sechium edule (Jacq.) Sw. (chayote), a neglected and underutilized Cucurbitaceae crop widely cultivated across tropical and subtropical regions, has drawn growing interest as a source of health-promoting food components. This review critically synthesizes studies published between 2000 and 2026 on its botanical features, genome characterization, nutritional value, phytochemistry, bioactivities, safety, and food-industry applications, based on literature retrieved from PubMed, Scopus, Web of Science, ScienceDirect, and the Cochrane Library. Different plant parts (fruits, leaves, seeds, tuberous roots, and peels) contain diverse bioactive compounds, including flavonoids, phenolic acids, cucurbitacins, pectin polysaccharides, and carotenoids. Reported bioactivities include antioxidant, anti-inflammatory, hypoglycemic, cardioprotective, antiproliferative, and geroprotective effects, mediated in part through Nrf2-mediated antioxidant signaling and sirtuin (SIRT1/3/5/6) upregulation. Notably, a systematic meta-analysis demonstrated a significant reduction in serum glucose (MD = −20.56; 95% CI: −29.35 to −11.77) and HbA1c following three months of chayote intake in patients with metabolic syndrome and type 2 diabetes. Industrially, chayote has been developed into fermented products, starch- and peel-derived bioactive films, ultrasound-extracted pectin, α-amylase inhibitory seed protein isolates, and probiotic encapsulation systems. Recent genomic work has further revealed a chromosome-level genome assembly, whole-genome duplication events, and a domestication history tracing to Mexico’s Oaxaca region. Collectively, this evidence positions chayote as a promising underutilized resource for food, nutraceutical, and biomedical use, while highlighting key gaps: the need for standardized clinical trials, bioavailability studies, and comprehensive safety evaluation.
Muhammad Bilal, Asad Abbas, Ralf Weiskirchen et al.· Foods· 0 citations
The reviewed literature indicates that the leaves are rich in monoterpenoid indole alkaloids, phenolic compounds, flavonoids, terpenoids, saponins, and steroids, which should emphasize raw material standardization, extraction optimization, toxicological evaluation, and preclinical and clinical validation to facilitate the development of safe, effective, standardized, and sustainable products.
Dikianur Alvianto, Nuzlul Musdalifah, Nova Solina Purba et al.· AJARCDE | Asian Journal of A...· 0 citations
Gastrodia elata, a medicinal and edible plant of the Orchidaceae family, has a long history of medicinal application and extensive development value in China. Endophytes permanently colonize G. elata and form a stable long-term symbiotic relationship with the host. The secondary metabolites produced by these fungi possess diverse structures and multiple biological activities, which are important sources for discovering novel bioactive ingredients that provide natural materials for screening and developing medicinal compounds. This article reviewed the research and development progress of endophytes associated with G. elata, including endophytes’ sources, biological functions, compound classification and pharmacological activities. The results showed that more than 296 secondary metabolites were reported—mainly terpenoids, polyketides, alkaloids, anthraquinones, phenolics—with prominently characterized antifeedant and antibacterial activities. Our work aims to provide scientific references for the in-depth exploration and efficient utilization of G. elata endophytic fungal resources.
Tian-zhen Xie, Kaize Shen, Wen-Jian Xia et al.· Journal of Fungi· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.